Register for APTA CSM in Philadelphia by Nov. 4 to save with early bird rates.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
May 29, 2019/Podcast
“Infant and Child Development: Innovations and Foundations for Rehabilitation.” By Jill Heathcock, PT, PhD, executive director of the Pediatric and Rehabilitation Laboratory (PEARL) at The Ohio State University; coeditor Jeffrey Lockman, PhD, professor of psychology at Tulane University’s Infant and
Jan 25, 2022/Perspective
Health insurance coverage for outpatient musculoskeletal rehabilitation disregards variability in prior level of function, rehabilitation progress, and personal recovery goals.
Aug 20, 2021/Open Access
What you need to know about the system's origins, the law that created it, and the ways APTA has been advocating for the profession.
Aug 1, 2016/Feature
Before purchasing a product, PTs and PTAs should ask a lot of questions. Some may be obvious. Others aren't. Here's what PTs, PTAs, and suppliers say are the questions to ask - and the answers to listen for - to help ensure you're making the right decision.
Jul 1, 2016/Feature
The distinction between insurers and hospital systems is fading. What does this mean for physical therapists?
Jun 1, 2016/Column
Should you tap the market? Some points to consider.
Mar 1, 2017/Feature
Find out about wireless brain-spinal interfaces, “soft robot” applications in rehabilitation, virtual reality systems for intermanual transfer, diagnosing concussions using hearing, stem cells to repair meniscal tears, and more.
Nov 1, 2016/Column
The power of optimism in wellness pursuits.
Sep 1, 2022/Feature
Lecturer Lisa VanHoose, PT, PhD, MPH, FAPTA, provided a sobering view of the profession's 'DEI fatigue' — and a possible path to overcome it.
Nov 11, 2021/CPG
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more
